Your browser doesn't support javascript.
loading
An efficient plasmid-based system for the recovery of recombinant vesicular stomatitis virus encoding foreign glycoproteins.
Marqués, María-Carmen; Andreu-Moreno, Iván; Sanjuán, Rafael; Elena, Santiago F; Geller, Ron.
Afiliação
  • Marqués MC; Institute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, 46980, Paterna, Valencia, Spain.
  • Andreu-Moreno I; Institute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, 46980, Paterna, Valencia, Spain.
  • Sanjuán R; Institute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, 46980, Paterna, Valencia, Spain.
  • Elena SF; Institute for Integrative Systems Biology (I2SysBio), CSIC-Universitat de València, 46980, Paterna, Valencia, Spain.
  • Geller R; The Santa Fe Institute, Santa Fe, NM, 87501, USA.
Sci Rep ; 14(1): 14644, 2024 06 25.
Article em En | MEDLINE | ID: mdl-38918479
ABSTRACT
Viral glycoproteins mediate entry into host cells, thereby dictating host range and pathogenesis. In addition, they constitute the principal target of neutralizing antibody responses, making them important antigens in vaccine development. Recombinant vesicular stomatitis virus (VSV) encoding foreign glycoproteins can provide a convenient and safe surrogate system to interrogate the function, evolution, and antigenicity of viral glycoproteins from viruses that are difficult to manipulate or those requiring high biosafety level containment. However, the production of recombinant VSV can be technically challenging. In this work, we present an efficient and robust plasmid-based system for the production of recombinant VSV encoding foreign glycoproteins. We validate the system using glycoproteins from different viral families, including arenaviruses, coronaviruses, and hantaviruses, as well as highlight their utility for studying the effects of mutations on viral fitness. Overall, the methods described herein can facilitate the study of both native and recombinant VSV encoding foreign glycoproteins and can serve as the basis for the production of VSV-based vaccines.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmídeos / Glicoproteínas Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmídeos / Glicoproteínas Limite: Animals / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Espanha
...